✦ LIBER ✦

Correlations between p21 expression and clincopathological finding, p53 gene and protein alteration, and survival in patients with endometrial carcinoma

✍ Scribed by Ito, Kiyoshi; Sasano, Hironobu; Matsunaga, Gen; Sato, Shinji; Yajima, Akira; Nasim, Suhail; Garret, Carleton T.

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 137 KB
Volume: 183
Category: Article
ISSN: 0022-3417
DOI: 10.1002/(sici)1096-9896(199711)183:3<318::aid-path925>3.0.co;2-0

No coin nor oath required. For personal study only.

✦ Synopsis

The p21 protein inhibits cyclin-dependent kinases and mediates cell-cycle arrest and cell differentiation. It is induced by wild-type p53, but not by mutant p53. This study of 75 patients with endometrial carcinoma investigates the relationship between p21 expression and the functional status of p53, and the usefulness of p21 as a prognostic marker. Correlations were determined between p21 immunoreactivity, p53 overexpression as examined by immunohistochemistry, p53 DNA mutations as examined by polymerase chain reaction-single-stranded conformation polymorphism (PCR-SSCP) analysis, and clinicopathological features, including the clinical outcome. Immunoreactivity for p21 and p53 mutations were detected in 47 (62.7 per cent), 37 (49 per cent), and 23 (31 per cent) patients, respectively. There were no significant correlations between the presence or absence of p21 immunoreactivity and p53 overexpression and DNA mutations. Survival curves revealed that patients with p53 overexpression tended to have a poorer prognosis than those without p53 overexpression (P = 0.104), that patients with p53 mutations had a significantly worse prognosis than those without mutations (P = 0.035), and that patients with p21 expression tended to have a better prognosis than those without p21 expression (P = 0.074). Immunohistochemical analysis of p21 was not useful for evaluating the functional status of p53 in patients with endometrial carcinoma. Both p21 expression and p53 abnormalities were considered as prognostic indicators in patients with endometrioid endometrial carcinoma.

📜 SIMILAR VOLUMES

Correlation between mutations in p53 gen

Correlation between mutations in p53 gene and protein expression in human lymphomas

✍ Martinez-Delgado, B.; Robledo, M.; Arranz, E.; Infantes, F.; Echezarreta, G.; Ma 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

A discordance between p53 protein overexpression and the presence of mutations in the gene has been observed in many types of tumors, including human lymphomas. To probe this finding, we have studied a large series of 94 lymphomas of different pathologic types and histologic differentiation. Analyzi

p53 protein accumulation and p53 gene mu

p53 protein accumulation and p53 gene mutation in esophageal carcinoma : A molecular and immunohistochemical study with clinicopathologic correlations

✍ Guido Coggi; Silvano Bosari; Massimo Roncalli; Daniela Graziani; Paola Bossi; Gi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

## Background: P53 gene mutation and p53 protein accumulation are common in human cancer. however, their clinical significance is controversial and p53 accumulation may not correlate with gene mutation. the current study investigates the occurrence of p53 alterations in esophageal carcinoma, the co

p21WAF1/CIP1 expression in colorectal ca

p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations

✍ Viale, Giuseppe; Pellegrini, Caterina; Mazzarol, Giovanni; Maisonneuve, Patrick; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

Defects in the mechanisms controlling the cell cycle are crucial in cell transformation and/or tumour progression. p21 WAF1/CIP1 is an inhibitor of cyclin-dependent kinases, induced by p53-dependent and p53-independent pathways, which can block progression through the cell cycle. p21 WAF1/CIP1 expre

Cyclin-d1-gene amplification and express

Cyclin-d1-gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 immunohistochemical expression

✍ Mattia Barbareschi; Paola Pelosio; Orazio Caffo; Fiamma Buttitta; Silvia Pellegr 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 162 KB 👁 1 views

Cyclin D1 is a major positive regulator of the G 1 restriction point promoting inactivation of the retinoblastoma protein (RB). The cyclin D1 gene is rearranged, amplified and/or over-expressed in several human neoplasms. In the present series of 64 human breast carcinomas, cyclin D1 amplification (

Flow cytometric DNA analysis and p53 pro

Flow cytometric DNA analysis and p53 protein expression show a good correlation with histologic findings in patients with barrett's esophagus

✍ Alberto Giménez; Alfredo Minguela; Pascual Parrilla; Juan Bermejo; Domingo Pérez 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

## BACKGROUND. There is a considerable degree of subjectivity and, therefore, substantial interobserver and intraobserver disagreement in the diagnosis and grading of dysplastic lesions in Barrett's esophagus (BE). The aim of this study was to evaluate the usefulness of DNA flow cytometry and immu

Subcellular localisation of cyclin D1 pr

Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21WAF1/CIP1 expression and correlates with patient survival

✍ Tracey A. Holland; Jackie Elder; Jonathan M. McCloud; Christine Hall; Mark Deaki 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 423 KB 👁 1 views